RPTX
Repare Therapeutics Inc
NASDAQ: RPTX · HEALTHCARE · BIOTECHNOLOGY
$2.65
+0.00% today
Updated 2026-01-28
Market cap
$114.24M
P/E ratio
—
P/S ratio
9.62x
EPS (TTM)
$-1.70
Dividend yield
—
52W range
$1 – $3
Volume
1.4M
Repare Therapeutics Inc (RPTX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-6.01M | $-12.62M | $-18.43M | $-6.08M | $-85.80M | $322000.00 | $-127.16M | $-76.44M |
| Capital expenditures | $1.16M | $583000.00 | $1.30M | $2.24M | $1.69M | $602000.00 | $1.94M | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | — | — | — | — | — | — |
| Free cash flow | $-7.16M | $-13.20M | $-19.73M | $-8.32M | $-87.49M | $-280000.00 | $-129.10M | $-76.44M |
| Investing cash flow | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $232.00M | $8.09M | — | — | — |